NJ CVS gives cancer meds to kids, not fluoride
TRENTON, N.J. (AP) - CVS officials say only a few children ingested pills for breast cancer treatment that they mistakenly received from a New Jersey pharmacy instead of the fluoride pills that were prescribed.
No injuries related to the mixup had been reported as of Saturday afternoon. The two pills are similar looking but have distinctively different tastes.
Investigators are still working to determine how and why the errors occurred at the CVS pharmacy in Chatham. The pharmacy has acknowledged improperly dispensing the breast cancer-fighting drug Tamoxifen instead of chewable fluoride tablets to children in as many as 50 families between Dec. 1 and Feb. 20.
Fluoride helps prevent tooth decay and is usually prescribed by dentists for children. Tamoxifen is used to treat breast cancer and blocks the female hormone estrogen.
THIS IS A BREAKING NEWS UPDATE. Check back soon for further information. AP’s earlier story is below.
The state attorney general's office has begun a preliminary investigation into a CVS pharmacy’s mistaken distribution of pills for the treatment of breast cancer to children instead of the fluoride pills that were prescribed.
The attorney general’s consumer affairs division on Friday ordered a CVS pharmacy in Chatham to explain the mistake and provide the names of all its employees along with all emails, telephone calls, complaints, and other information related to the mix-up.
The pharmacy must provide the information by Wednesday and company representatives must appear before division officials for questioning under oath, an order signed by division Director Thomas R. Calcagni said.
Meanwhile, CVS Caremark said in a statement that it was “deeply sorry for the mistake that occurred” at its pharmacy in northeastern New Jersey, although the company did not explain how the mistake happened. There has been no report of injury.
Calcagni’s administrative order said the pharmacy acknowledged it improperly dispensed the breast cancer fighting drug Tamoxifen instead of chewable fluoride tablets to children in as many as 50 families between Dec. 1, 2011, and Feb. 20. Calcagni said in the order that the division wants to look into whether any laws were violated.
Fluoride helps prevent tooth decay and is usually prescribed by dentists for children. Tamoxifen is used to treat breast cancer in men and women and blocks the female hormone estrogen.
Mike DeAngelis, CVS’s director of public relations, said in a statement that the company had contacted or left messages for every family whose child was dispensed a 0.5 mg fluoride prescription in the previous 60 days. He said that “most of the families we have spoken to did not indicate that their children received any incorrect pills.”
“The health and safety of our customers is our highest priority and we are deeply sorry for the mistake that occurred … ,” DeAngelis said.
He said the company would continue to follow up with families who believe their children may have ingested incorrect medication.
“We are actively investigating this matter to determine how the mistake occurred in order to take corrective actions to prevent this from happening again,” DeAngelis said.